sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
29-Mar-2015 02:16
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 951-975 out of 981.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>

Public Release: 26-Apr-2013
New drug stimulates immune system to kill infected cells in animal model of hepatitis B infection
A novel drug developed by Gilead Sciences and tested in an animal model at the Texas Biomedical Research Institute in San Antonio suppresses hepatitis B virus infection by stimulating the immune system and inducing loss of infected cells.
Gilead Sciences

Contact: Joseph Carey
Texas Biomedical Research Institute

Public Release: 25-Apr-2013
A*STAR, Veredus create market's first lab-on-chip to detect multiple tropical infectious diseases
The Agency for Science, Technology and Research and Veredus Laboratories, a leading supplier of innovative molecular diagnostic tools, announced the launch of VereTropTM, the first biochip in the molecular diagnostics market that can identify 13 different major tropical diseases from a single blood sample.
Agency for Science, Technology and Research

Contact: Dr. Sarah Chang
Agency for Science, Technology and Research (A*STAR), Singapore

Public Release: 25-Apr-2013
International Liver Congress 2013
New studies prove lethal link between alcohol, weight
Research announced today at the International Liver CongressTM 2013 has revealed the deadly impact that alcohol and body weight have on liver disease.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
Direct-acting antivirals now ready for prime time
New data from a number of clinical trials presented for the first time at the International Liver Congress™ 2013 demonstrate encouraging results in the use of new direct-acting antiviral agents for the treatment of hepatitis C.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 24-Apr-2013
International Liver Congress 2013
NASH diagnosis set to improve with non-invasive tool
A Chinese study presented at the International Liver CongressTM 2013 has demonstrated the accuracy of a non-invasive test for non-alcoholic steatohepatitis diagnosis.

Contact: Dimple Natali
European Association for the Study of the Liver

Public Release: 23-Apr-2013
AfriCoLeish receives funding boost from European Union
Research and development project, AfriCoLeish, is supported by the European Union Seventh Framework Programme through a grant of €3 million. The project will run for three years and aims to test new treatments for kala-azar (visceral leishmaniasis, or VL) and co-infection of the disease with HIV in Ethiopia and Sudan.
European Union

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 17-Apr-2013
7th Annual Sickle Cell Disease Research and Educational Symposium
Anti-sickling therapies should be focus for sickle cell science
Pain is an undeniable focal point for patients with sickle cell disease but it's not the best focus for drug development, says one of the dying breed of physicians specializing in the condition.

Contact: Toni Baker
Medical College of Georgia at Georgia Regents University

Public Release: 17-Apr-2013
Science Translational Medicine
HIV-infected moms who breastfeed exclusively have lower levels of virus in breast milk
HIV-infected women in sub-Saharan Africa who fed their babies exclusively with breast milk for more than the first four months of life had the lowest risk of transmitting the virus to their babies through breast milk. Women who stopped breast feeding earlier than four months had the highest concentrations of HIV in their breast milk, and those who continued to breastfeed, but not exclusively, had concentration levels in-between the two practices.

Contact: stephanie berger
Columbia University's Mailman School of Public Health

Public Release: 16-Apr-2013
TGen-led study discovers dramatic changes in bacteria following male circumcision
Male circumcision reduces the abundance of bacteria living on the penis and might help explain why circumcision offers men some protection against HIV, according to a study led by the Translational Genomics Research Institute.
National Institutes of Health, Northern Arizona University

Contact: Steve Yozwiak
The Translational Genomics Research Institute

Public Release: 16-Apr-2013
Haiti cholera mutations could lead to more severe disease
The cholera strain that transferred to Haiti in 2010 has multiple toxin gene mutations that may account for the severity of disease and is evolving to be more like an 1800s version of cholera.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Marla Paul
Northwestern University

Public Release: 15-Apr-2013
Proceedings of the National Academy of Sciences
La Jolla Institute's surprising finding could alter the face of dengue vaccine development
As efforts to create a strong and effective vaccine for the dreaded dengue virus continue to hit snags, a new study from researchers at the La Jolla Institute for Allergy & Immunology offers surprising evidence that suggests the need for a revamped approach to dengue vaccine design. The finding runs counter to current scientific understanding of the key cells that need to be induced to develop a successful dengue vaccine.

Contact: Bonnie Ward
La Jolla Institute for Allergy and Immunology

Public Release: 11-Apr-2013
Proceedings of the National Academy of Sciences
Discovery points to new approach to fight dengue virus
Researchers have discovered that rising temperature induces key changes in the dengue virus when it enters its human host, and the findings represent a new approach for designing vaccines against the aggressive mosquito-borne pathogen.
National Institutes of Health

Contact: Emil Venere
Purdue University

Public Release: 11-Apr-2013
Polio eradication is achievable by 2018 and urgent, declare 400+ global scientists
Hundreds of scientists and technical experts from 80 countries historically launched the Scientific Declaration on Polio Eradication on 11 Apr. 2013. The world has never been closer to a world free from polio. At this unique moment, scientists have come together to stress the achievability of polio eradication and endorse the Eradication and Endgame Strategic Plan, a new strategy by the Global Polio Eradication Initiative to reach and sustain eradication.

Contact: Dan Pawson
Global Health Strategies

Public Release: 11-Apr-2013
Leading organizations back Global Action Plan
More than 100 nongovernmental organizations and civil society organizations, joined by dozens of leading experts, expressed their support today for the World Health Organization and UNICEF's first-ever global plan to simultaneously tackle pneumonia and diarrhoea -- diseases that take the lives of almost two million children each year -- and urged governments and their partners to make the plan a reality.

Contact: Guillermo Meneses

Public Release: 11-Apr-2013
Cell-destroyer that fights and promotes TB reveals what's behind its split identity
TB can be a disease not only of failed immunity but also of excessive immune response. Tumor necrosis factor -- normally an infection-fighting substance produced by the body -- can actually heighten susceptibility to tuberculosis if its levels are too high.
National Institutes of Health, Northwest Regional Center of Excellence for Biodefense

Contact: Leila Gray
University of Washington

Public Release: 11-Apr-2013
Launch of semi-synthetic artemisinin a milestone for malaria, synthetic biology
The best therapy today for malaria is a drug combination that includes a derivative of artemisinin, now solely available from plants grown in Asia and Africa. On Apr. 11, Sanofi will launch the first semi-synthetic version of artemisinin, derived from yeast developed by biotech company Amyris from discoveries in the laboratory of Jay Keasling at UC Berkeley.
Gates Foundation

Contact: Robert Sanders
University of California - Berkeley

Public Release: 10-Apr-2013
Journal of Development and Behavioral Pediatrics
Training gives kids of AIDS patients a leg up
A simple in-home training program for caregivers can give children of AIDS patients a better shot at prosperity by improving their early-childhood development, according to a study led by a Michigan State University researcher.
National Institutes of Health

Contact: Andy McGlashen
Michigan State University

Public Release: 10-Apr-2013
In an economic crash, public health improves
The economic crash in Cuba following the fall of the Soviet Union has provided researchers with a unique natural experiment on obesity, diabetes and heart disease, according to a study in the British Medical Journal.

Contact: Jim Ritter
Loyola University Health System

Public Release: 10-Apr-2013
Bulletin of the World Health Organization
Researchers develop tool to assist areas of infectious disease outbreaks
Researchers have developed a simple new tool to help governments worldwide decide whether to screen airplane passengers leaving or arriving from areas of infectious disease outbreaks.
Canadian Institutes of Health Research

Contact: Leslie Shepherd
St. Michael's Hospital

Public Release: 10-Apr-2013
DNDi Latin America pledges 2013 Carlos Slim Health Award to chagas disease
The Drugs for Neglected Diseases initiative Latin America today announced that it will pledge the US $100,000 Carlos Slim Health Award to Chagas disease, the leading parasitic killer of the Americas.

Contact: Betina Moura
Drugs for Neglected Diseases Initiative

Public Release: 10-Apr-2013
Proceedings of the Royal Society B
Fighting disease from within the mosquito: New techniques to help halt the spread of disease
Scientists have revealed a new technique to introduce disease-blocking bacteria into mosquitoes, with promising results that may halt the spread of diseases such as dengue, yellow fever and potentially malaria.

Contact: Nerissa Hannink
University of Melbourne

Public Release: 9-Apr-2013
'Diseases of affluence' spreading to poorer countries
High blood pressure and obesity are no longer confined to wealthy countries, a new study has found.
Medical Research Council, NIH/National Institute for Health Research Imperial Biomedical Research Centres

Contact: Sam Wong
Imperial College London

Public Release: 9-Apr-2013
World Vaccine Congress
IDRI and Medicago to present data at the World Vaccine Congress
IDRI, a Seattle-based non-profit research organization that is a leading developer of adjuvants used in vaccines combating infectious disease, and Medicago Inc., a biopharmaceutical company focused on developing highly effective and competitive vaccines based on proprietary manufacturing technologies and Virus-Like Particles, will present positive interim Phase I clinical results for their H5N1 Avian Influenza VLP vaccine candidate.

Contact: Lee Schoentrup
Infectious Disease Research Institute

Public Release: 9-Apr-2013
PLOS Medicine
Treatment leads to near-normal life expectancy for people with HIV in South Africa
In South Africa, people with HIV who start treatment with anti-AIDS drugs (antiretroviral therapy) have life expectancies around 80 percent of that of the general population provided that they start treatment before their CD4 count drops below 200 (cells per microliter), according to a study by South African researchers published in this week's PLOS Medicine.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Fiona Godwin

Public Release: 8-Apr-2013
DNDi welcomes the Global Health Innovative Technology Fund (GHIT)
The Drugs for Neglected Diseases initiative (DNDi), based in Geneva, Switzerland, and DNDi Japan, based in Tokyo, welcome the launch of the Global Health Innovative Technology Fund, an initiative supported by the Japanese government, several Japanese pharmaceutical companies, and the Bill & Melinda Gates Foundation.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Showing releases 951-975 out of 981.

<< < 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>